114 related articles for article (PubMed ID: 37957898)
1. Identification of Key Prognostic Alternative Splicing Events of Costimulatory Molecule-Related Genes in Colon Cancer.
Ding H; Shi H; Chen W; Liu Z; Yang Z; Li X; Qiu Z; Zhuo H
Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 37957898
[TBL] [Abstract][Full Text] [Related]
2. Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma.
Qu Y; Chen Y; Zhang L; Tian L
World J Surg Oncol; 2020 Sep; 18(1):236. PubMed ID: 32883335
[TBL] [Abstract][Full Text] [Related]
3. Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction.
Xu J; Chen J; Cheng C; Li H; Gao P; Zheng J; Wang J
J Oncol; 2022; 2022():9952438. PubMed ID: 35126520
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
7. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
Wan Q; Sang X; Jin L; Wang Z
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
[TBL] [Abstract][Full Text] [Related]
8. Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.
Gong S; Song Z; Spezia-Lindner D; Meng F; Ruan T; Ying G; Lai C; Wu Q; Liang Y
Front Genet; 2020; 11():534. PubMed ID: 32595697
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
[TBL] [Abstract][Full Text] [Related]
10. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
11. Systematic profiling of alternative splicing events and splicing factors in left- and right-sided colon cancer.
Huang X; Liu J; Mo X; Liu H; Wei C; Huang L; Chen J; Tian C; Meng Y; Wu G; Xie W; P C FJ; Liu Z; Tang W
Aging (Albany NY); 2019 Oct; 11(19):8270-8293. PubMed ID: 31586988
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
Yang L; He Y; Zhang Z; Wang W
PeerJ; 2019; 7():e8245. PubMed ID: 31844595
[TBL] [Abstract][Full Text] [Related]
13. Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer.
Wang C; Zheng M; Wang S; Nie X; Guo Q; Gao L; Li X; Qi Y; Liu J; Lin B
Biomed Res Int; 2019; 2019():2686875. PubMed ID: 31355251
[TBL] [Abstract][Full Text] [Related]
14. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
[TBL] [Abstract][Full Text] [Related]
15. Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases.
Xie ZC; Gao L; Chen G; Ma J; Yang LH; He RQ; Li MW; Cai KT; Li TT; Peng ZG
Neoplasma; 2020 May; 67(3):623-635. PubMed ID: 32039631
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.
Chen J; Liao Y; Li R; Luo M; Wu G; Tan R; Xiao Z
Technol Cancer Res Treat; 2022; 21():15330338221090093. PubMed ID: 35509211
[No Abstract] [Full Text] [Related]
17. Identification of an alternative splicing signature as an independent factor in colon cancer.
Chen H; Luo J; Guo J
BMC Cancer; 2020 Sep; 20(1):904. PubMed ID: 32962686
[TBL] [Abstract][Full Text] [Related]
18. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
Liu Y; Jia W; Li J; Zhu H; Yu J
Front Oncol; 2020; 10():587343. PubMed ID: 33117720
[No Abstract] [Full Text] [Related]
19. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma.
Liang W; Sun F
Front Endocrinol (Lausanne); 2021; 12():538364. PubMed ID: 33776902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
